Destination: Cure

Contender in the Ring A novel HIV therapy targets & eradicates one cell type in the viral reservoir by Jeannie Wraight BIT225, an HIV VPU inhibitor, has...

For only the second time in the history of the AIDS pandemic, a patient with HIV in London seems to have been freed of...

Cure Research with a Heart Translation inhibitors may be part of a therapeutic strategy by Jeannie Wraight To date there are over 100 documented cases of HIV...

RIVER Dry Kick and kill strategy study yields disappointing results by Jeannie Wraight Latent HIV resides in cells in blood and tissue which we collectively call the...

Mosaic Design APPROACH, a preventive vaccine study, seeks to address more than one clade by Jeannie Wraight Over the past thirty-plus years, strategies such as Treatment as...

Another Road Broadly neutralizing antibodies aim for a diverse effect against HIV types by Jeannie Wraight and David Miller Broadly neutralizing antibodies (bNAbs) hold the potential of...

A new study published in the Journal of Immunology suggests that co-infection with toxoplasmosis (toxo), a parasitic infection common in people with AIDS, may...

Fast Look Cure research highlights from CROI 2018 by Jeannie Wraight The Conference on Retroviruses and Opportunistic Infections (CROI) provides an annual snapshot of the year’s most...

When first discussing the potential of writing a monthly column on HIV cure, my editor here at A&U Magazine asked a very valid question....

The Strength of Women The Imbokodo Study launches in Southern Africa by Jeannie Wraight In Zulu, the word “Imbokodo” means “rock” and is part of a well-known...